Genflow Biosciences PLC - Company to present at Animal Longevity Summit 2026

June 17, 2026 2:00 AM

Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company") an emerging leader in the field of longevity research, today announces that it has been invited to present data from its SLAB (Sarcopenia and Longevity in Aged Beagles) clinical study at the Animal Longevity Summit ("ALOS"), taking place in Toronto, Canada, on 1-2 October 2026.The SLAB study is designed to evaluate the potential of Genflow's centenarian SIRT6 gene...

Read more

Former DEA Section Chief Steps Forward to Challenge Marijuana Rescheduling Process

June 17, 2026 12:50 AM

As the Drug Enforcement Administration prepares for its June 29 marijuana rescheduling hearing, an unusual group of experts is emerging to challenge the government's approach. They are not politicians.They are not cannabis activists.They are not industry lobbyists.Instead, they are individuals whose careers were spent enforcing drug laws, developing FDA-regulated medicines, and protecting public health.Among them is Jorge Jimenez, a retired...

Read more

Onco-Innovations Completes Project with Kuano, Using Their Quantum-Based Platform to Deliver Insights for PNKP Inhibitor Technology Optimization

June 16, 2026 6:00 PM

Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce, further to its news release dated November 18, 2025, the completion of its pilot project with Kuano Ltd. ("Kuano"), supporting the continued advancement of Onco's PNKP Inhibitor Technology (also known as ONC010) through advanced AI-enabled and quantum-based computational approaches.Kuano has completed the project and...

Read more

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2026 Financial Results

June 16, 2026 4:15 PM

Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous acid (HOCl) products for a wide range of applications including wound care, eye care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants, today announced financial results for fiscal year 2026 and the fourth quarter ended March 31, 2026."Fiscal 2026 was a year...

Read more

Protagonist Therapeutics Reports Granting of Inducement Awards

June 16, 2026 4:00 PM

Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported that on June 15, 2026, it granted inducement awards to three recently hired employees in accordance with the terms of their employment offer letters. The awards were granted under the Protagonist Therapeutics Amended and Restated Inducement Plan, which was adopted May 29, 2018, and amended February 18, 2020 and February 15, 2022.The new employees received, in the aggregate, options to...

Read more

HonorBridge Names Joel Baucom Chief Operating Officer

June 16, 2026 10:00 AM

HonorBridge is pleased to announce that Joel Baucom, M.Div., has been named Chief Operating Officer. Baucom brings 15 years of experience at HonorBridge to the role, having served in a variety of positions across the organization, including Family Support Coordinator, Manager of Family Services, Director of Organ Operations and Director of Partner Engagement.Baucom earned a Master of Divinity from Campbell University Divinity School and a...

Read more

Medical Care Technologies (OTC PINK:MDCE) Discusses Enterprise-Grade Privacy Architecture for MDCE Melanoma Scan Beta

June 16, 2026 9:11 AM

Medical Care Technologies, Inc. (OTC PINK:MDCE) ("MDCE" or the "Company"), a technology company focused on artificial intelligence, imaging technologies, and digital wellness platforms, today provided an update on the privacy-focused architecture being incorporated into its MDCE Melanoma Scan Beta platform.The MDCE Melanoma Scan Beta platform is being developed as an AI-assisted imaging and skin wellness pre-screening technology designed to...

Read more

SoCal Aesthetic Surgery Expands Treatment Options With Addition of CO₂ SmartXide PRO Laser

June 16, 2026 9:00 AM

SoCal Aesthetic Surgery has expanded its non-surgical skin rejuvenation services with the addition of the CO₂ SmartXide PRO laser, a next-generation fractional resurfacing platform designed to improve skin quality with enhanced precision, customizable treatment settings, and minimal downtime. The practice, led by facial aesthetics specialist Dr. Homer Hojjat, continues to broaden treatment options for patients seeking effective solutions for sun...

Read more

MIB Agents' Community of Families Has Awarded $2.9M in Grants to Research Pediatric Bone Cancer

June 16, 2026 9:00 AM

MIB Agents, a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for its community of patients, caregivers, doctors, and researchers, announced today that since its inception in 2016, it has awarded $2.9 million to scientists across the country through its OutSmarting Osteosarcoma grant program. The OutSmarting Osteosarcoma grants are supported by MIB Agents Family Funds, osteosarcoma patients and families who raise research...

Read more

Barefoot Risks: Why Summer Activities Can Lead to Hidden Foot Injuries, According to Ankle & Foot Centers of America

June 16, 2026 9:00 AM

As temperatures rise and more people spend time outdoors, Ankle & Foot Centers of America is encouraging individuals to be mindful of the hidden risks that summer activities can pose to foot health.Whether walking barefoot at the beach, around the pool, or during outdoor recreation, feet are exposed to a variety of hazards including cuts, puncture wounds, burns from hot surfaces, and infections. Increased activity levels during the summer can...

Read more

Aetna Donates $130,000 to Kansas City Organizations To Support Nutrition, Mental Health, Maternal Health and Health-Related Social Needs

June 16, 2026 9:00 AM

Originally published on CVS Health Company NewsroomAetna Better Health of Missouri, a CVS Health company (NYSE:CVS), announced new collaborations with five local community-based organizations to support better health outcomes in the Kansas City area. Through donations totaling $130,000, Aetna is helping fund initiatives that address nutrition, mental health, maternal health and health-related social needs, reinforcing its commitment to building...

Read more

Poverty's Toll on Health Outcomes: What Little Rock's Own Data Reveals

June 16, 2026 9:00 AM

Arkansas's most populous county sits at the center of a healthcare paradox. Pulaski County is home to UAMS Medical Center, Baptist Health, and Arkansas Children's Hospital - over 3,000 physicians and 8,000 nurses serving a population of roughly 400,000. Yet the county's health outcomes tell a different story, one shaped less by clinical capacity than by the concentrated, compounding force of poverty.A review of publicly available data from the...

Read more

SpendMend Names Trey Cook as Chief Executive Officer

June 16, 2026 8:30 AM

SpendMend, the leading provider of cost cycle management solutions to the healthcare industry, announced today the appointment of Trey Cook as Chief Executive Officer. Cook succeeds founder Dan Geelhoed, who has served as CEO since founding the company in 1992.Cook brings more than two decades of experience leading high-growth healthcare technology organizations. Most recently, he served as President and CEO of STARLIMS and previously held the...

Read more

TRNR to Report Second Quarter 2026 Results on August 14, 2026; Expects Record Quarterly Revenue of Approximately $8 Million

June 16, 2026 8:30 AM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the Wattbike, CLMBR, FORME and Ergatta brands, today announced that it will report financial results for its second quarter ended June 30, 2026 on Thursday, August 14, 2026. This will be the first quarter TRNR will report fully consolidated Ergatta results and the Company expects to report record quarterly revenue and...

Read more

Black Book Study Finds Europe is Connected, But Not Yet Interoperable: Only 13% of Healthcare IT Users Say Vendors are EHDS-Ready

June 16, 2026 8:20 AM

Black Book Market Research today announced the availability of its new report, "2026 Europe Health Information System Interoperability, Connectivity & Connected Care Top Performers," available today to European healthcare IT stakeholders at https://blackbookmarketresearch.com/european-ehr-epr-interoperability-and-connected-care-top-performers-2026The report follows the recent Brussels EHDS interoperability meeting, where European health data...

Read more

Moderna Announces Organizational Changes to Prepare for Multiple Product Launches in 2027 and 2028

June 16, 2026 7:30 AM

Moderna, Inc. (NASDAQ:MRNA) today announced changes to its operating model to support its short- and long-term business goals.As Moderna executes its long-range plan to become a diversified, multi-modality biotechnology company, the Company is preparing to manage three commercial franchises while advancing a broad mRNA pipeline and investing in Moderna research and early development (mRED). Building on strong momentum in its infectious disease...

Read more

Cannabis Industry Attorney Concedes D.C. Circuit Challenge Could Reverse Marijuana Rescheduling

June 16, 2026 6:00 AM

MMJ International Holdings today highlighted a significant development in the ongoing legal challenge to the federal government's marijuana rescheduling order after cannabis industry attorney Jason Adelstone publicly acknowledged that the D.C. Circuit challenge brought by MMJ International Holdings and the National Drug and Alcohol Screening Association (NDASA) presents a substantial threat to the Schedule III rule. In a June 15 analysis...

Read more

Positive Results From The Phase Ib Clinical Study of NeuroRestore ACD856, Under Development for Alzheimer's

June 16, 2026 4:45 AM

AlzeCure Pharma AB (publ) (STO:ALZCUR)(FRA:AC6), a biotech company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that the Phase Ib clinical study of ACD856, the lead drug candidate in the NeuroRestore platform being developed for Alzheimer's disease and other indications, has been completed on schedule with positive results."Consistent with previous clinical...

Read more

Teknova Expands Digital Publication Experience with Bioz Content Hub Integration

June 16, 2026 4:00 AM

Bioz, Inc., an innovative platform focused on extracting and syndicating insights from scientific publications, announced its continued collaboration with Teknova, a leading manufacturer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Building on a long-standing collaboration, Teknova has expanded its use of Bioz Badges by implementing a fully customized Bioz...

Read more

IRLAB Presents Integrated Analysis of Mesdopetam Data at International Conference - Confirms Robust Efficacy Results in the Phase II Studies

June 16, 2026 1:15 AM

IRLAB Therapeutics AB ((STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for Parkinson's disease, today announces that an integrated analysis of clinical data for mesdopetam, IRLAB's most advanced drug candidate in development to treat levodopa-induced dyskinesia, will be presented at StanCon 2026 in Uppsala in August. The analysis confirms mesdopetam's anti-dyskinetic effect across a broad range of statistical...

Read more